IPO/ROUNDUP: Novartis will Alcon an die Börse bringen – Aktienrückkauf geplant

BASEL (dpa-AFX) – Der Schweizer Pharmakonzern Novartis sorgt für Klarheit über die Zukunft seiner lange kriselnden Augenheilsparte.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
666